Compare iShares International Treasury Bond ETF (IGOV) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares International Treasury Bond ETF vs Tempus AI — how do they compare? iShares International Treasury Bond ETF trades at $39.75 (market cap $1.31B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Tempus AI is far larger — about 9.7× iShares International Treasury Bond ETF's market cap, and Tempus AI is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares International Treasury Bond ETF for 92 Days and Tempus AI for 22 Days on average.
| IGOV | TEM | |
|---|---|---|
Market Cap | $1.31B | $12.77B |
Volume | 493,216 | 8,980,490 |
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $42.99 | $99.28 |
52-Week Low | $39.65 | $41.55 |
Typical Hold Time | 92 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IGOV is trading at $39.70, down 0.48% on the day, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks available fundamental data for key valuation and profitability metrics, creating uncertainty around its financial health. Recent market news highlights rising global bond yields, which could impact interest-rate sensitive sectors.
The outlook remains cautious due to the bearish technical setup and absence of fundamental clarity. Investment opportunities depend on forthcoming financial disclosures, while risks include market volatility from rising yields and the stock's technical weakness. Investors require updated earnings reports to assess true valuation.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
